ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. clinical trials

Also known as FDZJ.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 25 studies whose lead sponsor is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 28, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Shanghai Fudan-Zhangjiang Bio-Pharmaceutical with Beijing Biotech and Jecho Biopharmaceuticals →

Pipeline: 2 programs

Each counted once: 2 with a study Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.’s own registered studies; Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.’s studies test, most studies first; none is open now — 5 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

2 of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 25 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now624%Recruiting 5 · Not yet recruiting 1
  • Under way, not recruiting28%
  • Completed1560%
  • Stopped early28%

Phase

  • Phase 113
  • Phase 27
  • Phase 33
  • Phase 43

Where

  • China24
  • United States1

Over the years

  1. 11
  2. 12
  3. 13
  4. 14
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 521
  12. 22
  13. 23
  14. 24
  15. 25
  16. 126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

  • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies

Studies

Recruiting first, then most recently updated. Showing 25 of 25.